reason report weekli
 equal-weight medic devic out-perform
broad market index gain week
versu declin result medic
devic hospit suppli index continu close gap still lag
broad market under-perform
realiz gain versu year-to-d gain
look ahead calendar earn season conclud
coverag univers next week rate report
market close thursday decemb addit note
edward lifesci nr ew host compani annual investor
meet thursday decemb
misight industri first contact len indic slow
progress myopia children age year old
initi treatment recal link estim
million children high-myopia
penetr aforement million opportun could
lend million sale accordingli remain confid
abil conserv deliv organ revenu growth
coupl oper margin expans excess
double-digit non-gaap earn growth next year
monday novemb o/v rate announc
compani appoint fuad ahmad role interim chief
financi offic effect novemb mr ahmad partner
flg partner firm special deliv financi
oper leadership privat public compani mr ahmad
serv interim cfo perman successor appoint
tuesday novemb publish note e/v rate
follow attend align gp summit la
vega nevada weekend importantli weekend serv
bolster confid revenu growth stori
continu expand digit scan becom industri standard
care increasingli adopt clear align therapi
practic importantli compani continu evolv product
portfolio intern expans effort support
top-lin growth stori industri lead posit howev
import disclosur analyst certif page report report constitut compendium report cover six
subject compani stephen inc choos provid specif disclosur compani mention refer
access current disclosur compani report client refer
contact stephen inc repres addit inform
continu expect street model need incorpor modest margin assumpt out-year result
end-market price degrad requisit oper expenditur notabl sustain higher expens
potenti moder volum growth matur north american marketplac increasingli reflect
competit forc undercurr
also tuesday highlight key takeaway recent investor confer nashvil host
formal fire side chat present one-on-on meet compani formal coverag
assign ad emphasi o/v rate rate continu see potenti
rel out-perform versu corpor guidanc street consensu addit increment catalyst
enhanc growth profit also note rate outlook rel valuat remain compel
acknowledg compani face challeng annual growth comparison begin like
caus report top-lin growth revert histor mid single-digit rate
wednesday novemb rate alc report consensu oper result unveil multi-
year million cost reduct initi alc panoptix offer deliv solid growth larg
expect despit strong new product growth realiz oper margin object appear backend
load note primari concern recent initi link remain favor dispos
alc end market also compani posit global industri leadership robust new product pipelin
alc rel premium justifi current margin earn profil accordingli remain alc
share await either opportunist pull-back valuat improv line sight better forecast growth
margin expans revisit invest thesi
thursday novemb o/v rate announc close previous announc acquisit avedro
view acquisit favor avdr possess highli defens disrupt busi model scalabl
keratoconu today larger comprehens ophthalmolog marketplac longer term moreov pair
two ophthalm innov creat franchis scale multipl opportun leverag rx develop
capabl domain presenc drive averag growth margin recal enter definit
agreement acquir avedro billion equival revenu august year
time publish pro forma analysi combin compani price target estim remain unchang
immedi short run pend final review estim
notabl outsid coverag wednesday novemb rate announc sale
compani cynosur asset clear view revenu multipl assign cynosur appropri
cynosur asset rumor shop extens lack clinic differenti
organ growth gross margin profil versu gm profil lose money vs
profit perceiv substant pipelin accordingli opinion
cynosur million valuat indic distress asset sale acquisit growth asset remain
bullish growth margin expans profil well new evolv execut manag team
note dollar million except per share data ep alc
elgx fulli tax pro forma
rate stephen inc overweight equal-weight underweight volatil susp suspend
percentag chang price
compani document stephen inc estim rate
stephen inc otherwis estim base upon consensu
non-cov compani mention list figur page
analyst primarili respons prepar content report certifi view express report
accur reflect analyst person view subject compani secur ii part analyst compens
directli indirectli relat specif recommend view express analyst report
